PNC Financial Services Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.51K | Buy |
126
+11
| +10% | +$91 | ﹤0.01% | 4756 |
|
|
2026
Q1 | $964 | Sell |
115
-55
| -32% | -$578 | ﹤0.01% | 4765 |
|
|
2025
Q4 | $2.45K | Sell |
170
-148
| -47% | -$1.84K | ﹤0.01% | 4483 |
|
|
2025
Q3 | $3.07K | Buy |
318
+213
| +203% | +$1.88K | ﹤0.01% | 4381 |
|
|
2025
Q2 | $862 | Buy |
105
+30
| +40% | +$251 | ﹤0.01% | 4586 |
|
|
2025
Q1 | $536 | Sell |
75
-36
| -32% | -$268 | ﹤0.01% | 4632 |
|
|
2024
Q4 | $858 | Sell |
111
-3,956
| -97% | -$37.1K | ﹤0.01% | 4459 |
|
|
2024
Q3 | $42.7K | Buy |
4,067
+2,714
| +201% | +$33.1K | ﹤0.01% | 3167 |
|
|
2024
Q2 | $15.8K | Sell |
1,353
-573
| -30% | -$8.92K | ﹤0.01% | 3584 |
|
|
2024
Q1 | $40.6K | Buy |
1,926
+165
| +9% | +$2.94K | ﹤0.01% | 3094 |
|
|
2023
Q4 | $31.6K | Buy |
1,761
+746
| +73% | +$13.1K | ﹤0.01% | 3192 |
|
|
2023
Q3 | $16.7K | Sell |
1,015
-948
| -48% | -$17.2K | ﹤0.01% | 3519 |
|
|
2023
Q2 | $39.2K | Buy |
1,963
+999
| +104% | +$19.2K | ﹤0.01% | 3199 |
|
|
2023
Q1 | $18.2K | Sell |
964
-802
| -45% | -$17.7K | ﹤0.01% | 3543 |
|
|
2022
Q4 | $40.1K | Sell |
1,766
-81
| -4% | -$1.83K | ﹤0.01% | 3112 |
|
|
2022
Q3 | $49K | Buy |
1,847
+1,220
| +195% | +$36.2K | ﹤0.01% | 2991 |
|
|
2022
Q2 | $15K | Sell |
627
-1,363
| -68% | -$34.1K | ﹤0.01% | 3627 |
|
|
2022
Q1 | $65K | Sell |
1,990
-576
| -22% | -$16K | ﹤0.01% | 2963 |
|
|
2021
Q4 | $85K | Buy |
2,566
+913
| +55% | +$31.1K | ﹤0.01% | 2795 |
|
|
2021
Q3 | $70K | Sell |
1,653
-804
| -33% | -$28.9K | ﹤0.01% | 2859 |
|
|
2021
Q2 | $95K | Buy |
2,457
+1,181
| +93% | +$42.2K | ﹤0.01% | 2686 |
|
|
2021
Q1 | $43K | Sell |
1,276
-188
| -13% | -$8.02K | ﹤0.01% | 3066 |
|
|
2020
Q4 | $66K | Buy |
1,464
+1,056
| +259% | +$36.9K | ﹤0.01% | 2741 |
|
|
2020
Q3 | $11K | Sell |
408
-565
| -58% | -$18.4K | ﹤0.01% | 3472 |
|
|
2020
Q2 | $35K | Sell |
973
-256
| -21% | -$9.54K | ﹤0.01% | 2953 |
|
|
2020
Q1 | $39K | Sell |
1,229
-531
| -30% | -$22.1K | ﹤0.01% | 2772 |
|
|
2019
Q4 | $73K | Buy |
1,760
+1,106
| +169% | +$43.7K | ﹤0.01% | 2674 |
|
|
2019
Q3 | $23K | Sell |
654
-602
| -48% | -$24.4K | ﹤0.01% | 3287 |
|
|
2019
Q2 | $65K | Buy |
1,256
+66
| +6% | +$3.29K | ﹤0.01% | 2794 |
|
|
2019
Q1 | $68K | Buy |
1,190
+1,012
| +569% | +$50.1K | ﹤0.01% | 2773 |
|
|
2018
Q4 | $8K | Sell |
178
-3,736
| -95% | -$219K | ﹤0.01% | 3624 |
|
|
2018
Q3 | $296K | Sell |
3,914
-2,937
| -43% | -$212K | ﹤0.01% | 1965 |
|
|
2018
Q2 | $491K | Buy |
+6,851
| New | +$327K | ﹤0.01% | 1664 |
|
|
2016
Q3 | – | Sell |
-188
| Closed | -$2K | – | 4223 |
|
|
2016
Q2 | $2K | Sell |
188
-123,130
| -100% | -$1.37M | ﹤0.01% | 4207 |
|
|
2016
Q1 | $1.33M | Buy |
123,318
+123,266
| +237,050% | +$1.58M | ﹤0.01% | 1131 |
|
|
2015
Q4 | $1K | Buy |
+52
| New | +$1.03K | ﹤0.01% | 4347 |
|
Other funds holding RGNX
RG
PNC Financial Services Group's RGNX Position: Q2 2026 in Review
PNC Financial Services Group increased its Regenxbio (RGNX) stake by 9.6% in Q2 2026, buying an estimated $91 and bringing the position to 126 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4756.
PNC Financial Services Group first reported a position in RGNX in Q4 2015 and has held it in 36 quarters since. The position peaked at $1.33M in Q1 2016. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- PNC Financial Services Group held 126 shares of Regenxbio worth $1.51K as of Q2 2026.
- PNC Financial Services Group bought 11 Regenxbio shares in Q2 2026, an estimated $91.
- Regenxbio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4756 holding.
- PNC Financial Services Group first reported a position in Regenxbio in Q4 2015 and has held it in 36 quarters since.
- PNC Financial Services Group's Regenxbio position peaked at $1.33M in Q1 2016.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.